Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
about
Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin AIntermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agentsEffects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone massBone selective protective effect of a novel bone-seeking estrogen on trabecular bone in ovariectomized rats.Assessment of bone quality using finite element analysis based upon micro-CT images.Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible.Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats.Bone loss in the oestrogen-depleted rat is not exacerbated by sitagliptin, either alone or in combination with a thiazolidinedione.Estrogen-dependent efficacy of limb ischemic preconditioning in female rats.Alterations in collagen and mineral nanostructure observed in osteoporosis and pharmaceutical treatments using simultaneous small- and wide-angle X-ray scattering.
P2860
Q30422091-39E90027-2BB3-4445-9FE9-615B1E358ABFQ33841826-CDF7BB1C-BE93-43EB-9E3C-F6779DDA0B78Q35229871-E1E281B0-ABB5-48E6-835B-FE36EDAB9121Q35384673-3EF1C86D-D1B9-48A5-9D5B-B7ED207BC28BQ37029020-31F969B8-AFB6-4045-86AD-F3634343437DQ37398366-DBCD0425-40FD-4C26-ACB0-CD5F4D26B8CBQ39863746-65DE744F-7CD7-4F8E-BA73-33609B28A017Q41691219-070021E9-6268-4BB5-AB8F-38F0CC6DCCA6Q45913829-5963ED6C-F2A6-4DA1-A2D8-4D180754307DQ47747235-70296E9F-84A1-4AA2-B438-F8B5BCE2E6FBQ53455992-93627584-FD40-422A-9958-E44C215E6406
P2860
Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Maintenance of cancellous bone ...... risedronate, or reduced hPTH.
@en
Maintenance of cancellous bone ...... risedronate, or reduced hPTH.
@nl
type
label
Maintenance of cancellous bone ...... risedronate, or reduced hPTH.
@en
Maintenance of cancellous bone ...... risedronate, or reduced hPTH.
@nl
prefLabel
Maintenance of cancellous bone ...... risedronate, or reduced hPTH.
@en
Maintenance of cancellous bone ...... risedronate, or reduced hPTH.
@nl
P2093
P1433
P1476
Maintenance of cancellous bone ...... risedronate, or reduced hPTH.
@en
P2093
Iwaniec UT
Samnegård E
P304
P356
10.1016/S8756-3282(01)00582-8
P577
2001-10-01T00:00:00Z